Daré Bioscience, Inc. DARE

Company Overview

Daré Bioscience, Inc. is a U.S.-based biopharmaceutical company focused on developing and commercializing products in women’s health. The company operates primarily within the biotechnology and specialty pharmaceutical industries, with a strategic emphasis on reproductive health, contraception, sexual health, fertility, and menopause-related conditions. Daré’s business model centers on advancing a portfolio of clinical-stage and commercial-stage therapeutic candidates through internal development, licensing arrangements, strategic collaborations, and commercialization partnerships.

The company’s primary revenue drivers have historically included licensing agreements, collaboration payments, grant funding, and, to a lesser extent, product-related revenue associated with partnered commercialization efforts. Daré has positioned itself as a women’s health-focused innovator targeting areas that have historically seen limited pharmaceutical investment, particularly non-hormonal and patient-centric treatment options. The company traces its origins to a reverse merger completed in 2017 between Cerulean Pharma Inc. and Daré Bioscience Operations, Inc., after which the combined entity adopted the Daré Bioscience name and strategy focused exclusively on women’s health therapeutics.